[Retracted] Establishment and Evaluation of Influencing Factors and Risk Prediction Model of Severe Neonatal Hyperbilirubinemia Complicated with Acute Bilirubin Encephalopathy
Table 1
Univariate analysis of ABE in neonates with severe hyperbilirubinemia.
Factor
ABE group (n = 26)
Non-ABE group (n = 94)
χ2/t
Gender
Male
17 (23.29)
56 (76.71)
0.289
0.591
Female
9 (19.15)
38 (80.85)
Gestational age (weeks)
38.96 ± 0.92
39.09 ± 0.69
0.788
0.432
Birth weight (kg)
3.15 ± 0.52
3.22 ± 0.46
0.667
0.506
Feeding method
Nonfull breastfeeding
14 (33.33)
28 (66.67)
5.182
0.023
Full breastfeeding
12 (15.38)
66 (84.62)
Acidosis
Yes
6 (31.58)
13 (68.42)
1.307
0.253
No
20 (19.80)
81 (80.20)
High-risk symptoms
Yes
11 (35.48)
20 (64.52)
4.702
0.030
No
15 (16.85)
74 (83.15)
TSB (μmol/L)
476.20 ± 38.25
449.07 ± 36.31
3.333
0.001
B/A (mg/g)
8.05 ± 0.81
7.21 ± 0.79
4.716
<0.001
Hb (g/L)
168.51 ± 16.08
152.76 ± 14.92
4.685
<0.001
Hct (%)
47.09 ± 5.17
43.15 ± 4.97
3.547
0.001
ALP (g/L)
35.64 ± 3.85
34.71 ± 3.61
1.146
0.254
CK-MB (U/L)
31.25 ± 2.97
30.11 ± 2.74
1.844
0.068
Maternal age (years)
＞35
9 (27.27)
24 (72.73)
0.843
0.359
≤35
17 (19.54)
70 (80.46)
Delivery mode
Cesarean delivery
13 (26.00)
37 (74.00)
0.948
0.330
Vaginal delivery
13 (18.57)
57 (81.43)
Parity
Firstborn
18 (26.47)
50 (73.53)
2.134
0.144
N-firstborn
8 (15.38)
44 (84.62)
Pregnancy complications
Yes
10 (37.04)
17 (62.96)
4.849
0.028
No
16 (17.20)
77 (82.80)
Childbirth complications
Yes
5 (31.25)
11 (68.75)
0.999
0.318
No
21 (20.19)
83 (79.81)
Note: Table 1 is a preliminary analysis of neonatal-related data.
